Clinical trial Recruiting at 1 site Observational Ages 25 to 80

Targeting abnormal blood flow to treat chronic joint pain in veterans

Official title: Perfusion MRI-targeted Joint Embolization to Diagnose and Treat Neovascularity Associated With Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee: A Prospective Cohort Study

Run by Palo Alto Veterans Institute for Research · NCT05700682 · Data updated 2026-11-12

This study is testing if treating abnormal blood flow in the joints can help veterans with chronic pain and osteoarthritis feel better.

More Osteoarthritis, Knee trials

Quick facts

Study typeObservational
Ages25 Years to 80 Years
SexAll
Enrollment120 (estimated)
SponsorPalo Alto Veterans Institute for Research
Academic / other
Locations1 site (Palo Alto, California)
StatusRecruiting
StartedJuly 15, 2023
Main results expectedMarch 1, 2026
Study endsAugust 1, 2026
Registry record updatedAugust 7, 2025
Trial IDNCT05700682 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are veterans with chronic shoulder, hip, or knee pain and mild to moderate degenerative changes who have not responded to standard treatments.

Probably not a fit

Patients with acute injuries or those without evidence of abnormal blood flow on MRI may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the connection between chronic musculoskeletal pain and abnormal blood flow around the shoulder, hip, and knee in veterans. Participants with a history of chronic pain and mild to moderate osteoarthritis will undergo perfusion MRI to assess blood flow in their joints. Those with abnormal blood flow may be offered a joint embolization treatment, while others will be monitored over time to understand the natural progression of their condition. The study aims to gather data that could lead to new treatment options for chronic joint pain.

Why it matters

Potential benefit: If successful, this approach could provide a novel treatment option for veterans suffering from chronic joint pain.

How similar studies have gone: While the approach of targeting neovascularity is innovative, similar studies have shown promise in treating chronic pain through embolization techniques.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (Both Arms):

1. Participants must be Veterans who receive care in the VA system.
2. Participants must have a history of chronic pain of the shoulder, hip or knee for at least 1 year.
3. Participants must have mild to moderate degenerative changes of the painful joint as depicted on prior imaging (X-ray, CT or MRI).
4. Participants must have undergone at least one failed primary treatment for their chronic pain (e.g. physical therapy, NSAIDs, steroid injection).
5. Participants must have an MRI of their painful joint (shoulder, hip or knee) ordered by a clinical provider.

Inclusion Criteria (Therapeutic Arm):

1. Participants must have enrolled in the Diagnostic Arm of the study and must have undergone perfusion MR imaging of their painful joint.
2. Participants must have evidence of peri-articular hypervascularity on their perfusion MR exams. This will be determined by the study PIs.

Exclusion Criteria (Diagnostic Arm):

1. Acute injury in the last 12 weeks.
2. Age under 25.
3. Severe degenerative changes of painful joint (shoulder, hip or knee).
4. History of arthroplasty or metallic implant within the painful joint.
5. Severe gadolinium contrast allergy.
6. Severe renal disease or ongoing dialysis.
7. History of malignancy with life expectancy of less than one year, or malignancy with known bone metastasis.
8. Current pregnancy.
9. Formal diagnosis of cognitive impairment.

Exclusion Criteria (Therapeutic Arm):

1. Severe iodinated contrast allergy.
2. Severe coronary or peripheral arterial disease.
3. Coagulopathy.
4. Uncontrolled type 2 diabetes or diabetic neuropathy.
5. History of seizures or other severe complication from conscious sedation.
6. Prior upper or lower extremity arterial bypass.
7. Ongoing participation in another interventional (therapeutic) trial for chronic joint pain.
8. Lack of peri-articular hypervascularity on initial perfusion MRI.
9. All exclusion criteria for the Diagnostic Arm.

Where it's running

  • VA Palo Alto Healthcare System
    Palo Alto, California, United States
    Recruiting

Study contacts

  • Principal investigator: Sirish Kishore, MD — VA Palo Alto Health Care System
  • Study coordinator: Eric Bultman, MD, PhD
  • Email: eric.bultman1@va.gov
  • Phone: 560-493-5000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.